Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
Nat Struct Mol Biol
; 27(6): 529-532, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-222247
ABSTRACT
The antineoplastic drug carmofur is shown to inhibit the SARS-CoV-2 main protease (Mpro). Here, the X-ray crystal structure of Mpro in complex with carmofur reveals that the carbonyl reactive group of carmofur is covalently bound to catalytic Cys145, whereas its fatty acid tail occupies the hydrophobic S2 subsite. Carmofur inhibits viral replication in cells (EC50 = 24.30 µM) and is a promising lead compound to develop new antiviral treatment for COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cysteine Endopeptidases
/
Viral Nonstructural Proteins
/
Fluorouracil
/
Betacoronavirus
Limits:
Animals
Language:
English
Journal:
Nat Struct Mol Biol
Journal subject:
Molecular Biology
Year:
2020
Document Type:
Article
Affiliation country:
S41594-020-0440-6
Similar
MEDLINE
...
LILACS
LIS